Autoinjector Contract Manufacturing Market Exclusive Overview Report | 2024-2031

Autoinjector Contract Manufacturing Market worth $2.80 billion by 2030 - Exclusive Report by InsightAce Analytic

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " "Global Autoinjector Contract Manufacturing Market By Product (Disposable Autoinjectors, Reusable Autoinjectors, Wearable Injector, and Smart/Connected Autoinjectors), Application (Anaphylaxis, Rheumatoid Arthritis, Multiple Sclerosis, Diabetes, and Others), End-User (Homecare, Hospitals & Clinics, and Ambulatory Services))- Trends, Industry Competition Analysis, Revenue and Forecast To 2030."
According to the latest research by InsightAce Analytic, the global autoinjector contract manufacturing market is valued at US$ 1.16 billion in 2021, and it is expected to reach US$ 2.80 billion by 2030, with a CAGR of 10.4% during the forecast period of 2022-2030.
Get Free Sample Copy of Report : https://www.insightaceanalytic.com/request-sample/1340
Autoinjector devices are helpful for rapidly administering pharmaceuticals and antidotes; even those without medical training can use them. Consequently, they are beneficial for emergency and mass casualty management. Autoinjectors are frequently used for the self-administration of epinephrine (to prevent anaphylaxis), by migraine sufferers (for rapid pain alleviation), and for medical and emergency treatments. Autoinjectors are acquiring widespread popularity among patients with conditions requiring multiple injections per day. The increasing number of patients with rheumatoid arthritis, multiple sclerosis, diabetes, and growth hormone disorders is one of the fundamental forces propelling the Autoinjector Contract Manufacturing market. Autoinjectors are gaining popularity because they enable patients to inject their medication without hesitating due to needle phobia. Patient care and comfort are of the utmost importance to caregivers and patients; Autoinjectors allow patients to self-administer doses without needing medical expertise. Autoinjectors can be used anywhere without causing the user or others discomfort. Autoinjectors reduce the cost per injection for the user because the device's primary body does not need to be replaced after each infusion.
Increased R&D efforts by companies to design accessible, cost-effective, and innovative technology-based autoinjectors for treating chronic diseases, as well as rising demand for and production of biologics, are impeding the growth of the Autoinjector industry. Ingenious, cost-effective remedies for chronic diseases such as multiple sclerosis and rheumatoid arthritis are being developed by companies engaged in research and development. The market's value is anticipated to increase and reach incredibly high levels.
The preference for alternative routes of medication administration, such as oral diabetes regimens and nasal epinephrine sprays, is expected to reduce the use of Autoinjector devices. Developing needle-free medication administration techniques like jet injectors also inhibits market expansion.
The North American region is anticipated to account for the largest autoinjector contract manufacturing market share. The area is home to a sizeable elderly population that relies on injections to manage conditions such as diabetes and rheumatoid arthritis. Significant regional insurance programs have also expanded the Autoinjector Contract Manufacturing market. The technological innovations of the vendors, especially the development of intelligent Autoinjectors, have contributed to their dominance in the North American market.
Enquiry Before Buying: https://www.insightaceanalytic.com/enquiry-before-buying/1340
Major market players operating in the autoinjector contract manufacturing market include Phillips-Medisize (a Molex Company), Elcam Drug Delivery Devices (E3D) (Elcam Medical), Jabil Healthcare, Gerresheimer AG, Dali Medical Devices, Ypsomed Delivery Systems (YDS), SHL Medical, Haselmeier, Owen Mumford, Becton, Dickinson and Company (BD), CCBio, Nemera (Copernicus), Recipharm AB, Sonceboz, Solteam Medical, Stevanato Group, Union Medico ApS., Neuma Engineering, Emperra, Eitan Medical, Enable Injections, West Pharmaceutical Services, Inc., Delfu Medical, Wanhai Medical, and Other Prominent Player
Key developments in the market:
• In June 2022, Jabil Healthcare launched the Qfinity autoinjector platform, a reusable and modular solution for subcutaneous (S.C.) drug self-administration that intends to address the pharmaceutical industry's increasing priority of sustainable drug delivery. The Qfinity+ autoinjector, a linked version of the handheld device, enables medical teams to remotely monitor their patients' treatment and compliance thanks to integrated sensors and electronics.
• In July 2022, SHL Medical unveiled plans for a new production location in the U.S. in response to the expanding market demand for its autoinjector product range. The decision arises from SHL's strategic considerations in increasing its manufacturing in North America. In 2019, SHL created a long-term plan in response to the expanding autoinjector demand and to satisfy future production demands. The news of the new U.S. business corresponds with the company's continued development, including a new Swiss facility currently being revealed.
• In May 2021, Phillips-Medisize launched the Aria Smart Autoinjector platform to enable innovation, distinction and sustainability in the digital drug-delivery device industry. This newest breakthrough delivers a tiny and simple, smart injection device with a reusable electronic drive unit and single-use, disposable cassettes to boost patient care while lowering environmental impact.
• In Mach 2020, SHL Medical recently announced the acquisition of Weibel CDS, a provider of new packaging and devices for drug administration in the field of medical technology.
Market Segments
Global Autoinjector Contract Manufacturing Market, by Product, 2020-2030 Value (US$ Mn) and Volume (No. of Units)
• Disposable Autoinjectors
• Reusable Autoinjectors
• Wearable Injector
• Smart/Connected Autoinjectors
Global Autoinjector Contract Manufacturing Market, by Application, 2020-2030 Value (US$ Mn) and Volume (No. of Units)
• Anaphylaxis
• Rheumatoid Arthritis
• Multiple Sclerosis
• Diabetes
• Others
Global Autoinjector Contract Manufacturing Market, by End-User, 2020-2030 Value (US$ Mn) and Volume (No. of Units)
• Homecare
• Hospitals & Clinics
• Ambulatory Services
Global Autoinjector Contract Manufacturing Market, by Region, 2020-2030 Value (US$ Mn) and Volume (No. of Units)
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa
North America Autoinjector Contract Manufacturing Market, by Country, 2020-2030 Value (US$ Mn) and Volume (No. of Units)
• U.S.
• Canada
Europe Autoinjector Contract Manufacturing Market, by Country, 2020-2030 Value (US$ Mn) and Volume (No. of Units)
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe
Asia Pacific Autoinjector Contract Manufacturing Market, by Country, 2020-2030 Value (US$ Mn) and Volume (No. of Units)
• India
• China
• Japan
• South Korea
• Australia & New Zealand
Latin America Autoinjector Contract Manufacturing Market, by Country, 2020-2030 Value (US$ Mn) and Volume (No. of Units)
• Brazil
• Mexico
• Rest of Latin America
Middle East & Africa Autoinjector Contract Manufacturing Market, by Country, 2020-2030 Value (US$ Mn) and Volume (No. of Units)
• GCC Countries
• South Africa
• Rest of Middle East & Africa
For More Customization @ https://www.insightaceanalytic.com/customisation/1340

Why should buy this report:
 To receive a comprehensive analysis of the manufacturing prospects for the global autoinjector market
 To receive an industry overview and future trends of the autoinjector contract manufacturing market
 To analyze the Autoinjector Contract Manufacturing market drivers and challenges
 To get information on the Autoinjector Contract Manufacturing market size Value (US$ Mn) and Volume (No. of Units) forecast to 2030
 To get information on major investments, mergers & acquisitions in the autoinjector contract manufacturing industry
Other Related Reports Published by InsightAce Analytic:
Global Pre-Fillable Syringe Closures and Accessories Market
Global Needle-Free Injectors Market
Global Biosimilar/Generic Injectable Pens Market
Global Pneumatic Nebulizers Market
Global Autoinjectors Market

Contact Us:
InsightAce Analytic Pvt. Ltd.
Tel.: +1 718 593 4405
Email: info@insightaceanalytic.com
Site Visit: www.insightaceanalytic.com
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

This release was published on openPR.